• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-022
Device Problem Material Deformation (2976)
Patient Problems Tissue Damage (2104); No Consequences Or Impact To Patient (2199)
Event Date 08/20/2018
Event Type  Injury  
Event Description
On (b)(6) 2018, a 22mm amplatzer septal occluder was selected for use with a 10fr delivery catheter.Upon deployment, the device formed into a cobra shape.The physician did not have complete visibility during the procedure, but states that the device did not sit properly so he resheathed the device twice in an attempt to fix the cobra shape, without success.The device was removed and deployed outside the patient, still taking on the cobra shape.Another physician resheathed the device and deployed it (outside the patient) and the occluder took on the proper shape.Tissue was noted on the device when initially removed from the patient.A new 24mm amplatzer septal occluder was used to successfully complete the procedure.The procedure was not significantly extended.The physician did see the deformation as a malfunction but reported it was not one that would result in patient harm.The patient was hemodynamically stable throughout the procedure and was discharged.
 
Manufacturer Narrative
The reported event of deformity upon deployment could not be confirmed.The investigation confirmed the device met functional specifications when analyzed at abbott under non-physiological conditions.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.The cause of the reported event remains unknown.Information from the field indicated that a 10f delivery sheath was used.Please note, per the instructions for use artmt100116885 ver a, the recommended delivery system size for this device is 9f.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
stephanie o' sullivan
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key7879562
MDR Text Key120379635
Report Number2135147-2018-00151
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806010182
UDI-Public00811806010182
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2023
Device Model Number9-ASD-022
Device Catalogue Number9-ASD-022
Device Lot Number6328573
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/19/2018
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/20/2018
Initial Date FDA Received09/14/2018
Supplement Dates Manufacturer Received11/29/2018
Supplement Dates FDA Received12/20/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/20/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-